Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding

被引:60
作者
Buckway, CK [1 ]
Wilson, EM
Ahlsén, M
Bang, P
Oh, Y
Rosenfeld, RG
机构
[1] Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97201 USA
[2] Karolinska Hosp & Inst, Dept Woman & Child Hlth, Stockholm, Sweden
关键词
D O I
10.1210/jc.86.10.4943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The N-terminal domain is conserved in all members of the IGF-binding protein superfamily. Most recently, studies have demonstrated the importance of an IGF-binding protein N-terminal hydrophobic pocket for IGF binding. To examine more critically the amino acids important for IGF binding within the full-length IGF-binding protein-3 protein while minimizing changes in the tertiary structure, we targeted residues I56, L80, and L81 within the proposed hydrophobic pocket for mutation. With a single change at these sites to the nonconserved glycine there was a notable decrease in binding. A greater reduction was seen when both L80 and L81 were substituted with glycine, and complete loss of affinity for lGF-I and IGF-II occurred when all three targeted amino acids were changed to glycine. Furthermore, the ability of the IGF-binding protein-3 mutants to inhibit IGF-I-stimulated phosphorylation of its receptor was a reflection of their affinity for IGF, with the lowest affinity mutants having the least inhibitory effect. These studies, thus, support the hypothesis that an N-terminal hydrophobic pocket is the primary site of high affinity binding of IGF to IGF-binding protein-3. The mutants provide a tool for future studies directed at IGF-dependent and IGF-independent actions of IGF-binding protein-3.
引用
收藏
页码:4943 / 4950
页数:8
相关论文
共 33 条
[1]   CARBOXY-TRUNCATED INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-5 STIMULATES MITOGENESIS IN OSTEOBLAST-LIKE CELLS [J].
ANDRESS, DL ;
LOOP, SM ;
ZAPF, J ;
KIEFER, MC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (01) :25-30
[2]   The IGF axis and programmed cell death [J].
Butt, AJ ;
Firth, SM ;
Baxter, RC .
IMMUNOLOGY AND CELL BIOLOGY, 1999, 77 (03) :256-262
[3]   PROTEOLYTIC CLEAVAGE OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-4 (IGFBP-4) - LOCALIZATION OF CLEAVAGE SITE TO NONHOMOLOGOUS REGION OF NATIVE IGFBP-4 [J].
CHERNAUSEK, SD ;
SMITH, CE ;
DUFFIN, KL ;
BUSBY, WH ;
WRIGHT, G ;
CLEMMONS, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11377-11382
[4]  
Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6
[5]  
COHEN P, 1993, GROWTH REGULAT, V3, P23
[6]   SOLUTION STRUCTURE OF HUMAN INSULIN-LIKE GROWTH FACTOR-I - A NUCLEAR-MAGNETIC-RESONANCE AND RESTRAINED MOLECULAR-DYNAMICS STUDY [J].
COOKE, RM ;
HARVEY, TS ;
CAMPBELL, ID .
BIOCHEMISTRY, 1991, 30 (22) :5484-5491
[7]   Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling [J].
Devi, GR ;
Yang, DH ;
Rosenfeld, RG ;
Oh, YM .
ENDOCRINOLOGY, 2000, 141 (11) :4171-4179
[8]   Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum [J].
Durham, SK ;
Mohan, S ;
Liu, F ;
Baker, BK ;
Lee, PDK ;
Hintz, RL ;
Conover, CA ;
Powell, DR .
PEDIATRIC RESEARCH, 1997, 42 (03) :335-341
[9]   INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN-3 (IGFBP-3) FUNCTIONS AS AN IGF-REVERSIBLE INHIBITOR OF IGFBP-4 PROTEOLYSIS [J].
FOWLKES, JL ;
SERRA, DM ;
ROSENBERG, CK ;
THRAILKILL, KM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27481-27488
[10]   Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit [J].
Hashimoto, R ;
Ono, M ;
Fujiwara, H ;
Higashihashi, N ;
Yoshida, M ;
EnjohKimura, T ;
Sakano, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27936-27942